Search research articles
Contact Us
Filters
Showing results (71-80 of 121) with videos related to
Page
of 13
Sort By:
Cytometry. Part B, Clinical Cytometry
|
September 6, 2005
Comparison of two methods for enumerating circulating tumor cells in carcinoma patients
Marija Balic, Nadia Dandachi, Günter Hofmann, et al.
Cancers
|
June 2, 2021
Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity
Christoph Suppan, Florian Posch, Hannah Deborah Mueller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2019
Prediction of Distant Recurrence Using EndoPredict Among Women with ER<sup>+</sup>, HER2<sup>-</sup> Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only
Martin Filipits, Peter Dubsky, Margaretha Rudas, et al.
Breast (Edinburgh, Scotland)
|
January 7, 2026
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trial
Christian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, et al.
NPJ Precision Oncology
|
November 9, 2024
Immune infiltration correlates with transcriptomic subtypes in primary estrogen receptor positive invasive lobular breast cancer
Fangyuan Chen, Sayali Onkar, Jian Zou, et al.
Molecular Oncology
|
June 13, 2024
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression
Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, et al.
British Journal of Cancer
|
November 10, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients
Christoph Suppan, Ricarda Graf, Stephan Jahn, et al.
BMC Cancer
|
November 8, 2018
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
American Journal of Clinical Pathology
|
February 26, 2026
Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer
Jacob A Jerome, Rachel Vanderschelden, Beth Z Clark, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 15, 2025
Interim Analysis of Dose-Escalated Preoperative Breast Irradiation: A Phase Ib study
Ravi Patel, Emilia Diego, Hayeon Kim, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 121) with videos related to
Sort By:
Page
of 13
Cytometry. Part B, Clinical Cytometry
|
September 6, 2005
Comparison of two methods for enumerating circulating tumor cells in carcinoma patients
Marija Balic, Nadia Dandachi, Günter Hofmann, et al.
Cancers
|
June 2, 2021
Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity
Christoph Suppan, Florian Posch, Hannah Deborah Mueller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2019
Prediction of Distant Recurrence Using EndoPredict Among Women with ER<sup>+</sup>, HER2<sup>-</sup> Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only
Martin Filipits, Peter Dubsky, Margaretha Rudas, et al.
Breast (Edinburgh, Scotland)
|
January 7, 2026
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trial
Christian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, et al.
NPJ Precision Oncology
|
November 9, 2024
Immune infiltration correlates with transcriptomic subtypes in primary estrogen receptor positive invasive lobular breast cancer
Fangyuan Chen, Sayali Onkar, Jian Zou, et al.
Molecular Oncology
|
June 13, 2024
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression
Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, et al.
British Journal of Cancer
|
November 10, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients
Christoph Suppan, Ricarda Graf, Stephan Jahn, et al.
BMC Cancer
|
November 8, 2018
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
American Journal of Clinical Pathology
|
February 26, 2026
Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer
Jacob A Jerome, Rachel Vanderschelden, Beth Z Clark, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 15, 2025
Interim Analysis of Dose-Escalated Preoperative Breast Irradiation: A Phase Ib study
Ravi Patel, Emilia Diego, Hayeon Kim, et al.
Page
of 13